Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation, and an exciting new book on environmental, social, and governance (ESG) investing. Our interview this week is with Sally Pipes, President and CEO of the Pacific Research Institute. We’ll talk about health care, pharmaceutical drugs, price controls, and the expensive work of research and development. Read Sally’s recent op-ed, “D.C.’s Embrace of Price Controls Bad News for Patients,” here.
Recent episodes:
- Free the Economy Episode 126: Tariffs and Corruption with Justin Callais
- Free the Economy Episode 125: Protecting Consumer Credit with Caroline Melear
- Free the Economy Episode 124: Next Steps for Nuclear with Deric Tilson
- Free the Economy Episode 123: Reforming Medicaid with Brian Blase
- Free the Economy Episode 122: Dear Mr. President with Destry Edwards
- Free the Economy Episode 121: Waste, Fraud, and Tax Hikes with Emily Ekins
- Free the Economy Episode 120: Reforming Washington’s 10,000 Commandments with Wayne Crews
- Free the Economy Episode 119: Economic Ideas for American Workers with Ryan Young
- Free the Economy Episode 118: Trade Myths (and Facts) with Prof. Michael Coon
- Free the Economy Episode 117: An Affordable and Reliable Future with Gabriella Hoffman
Join us next week when our guest will be Dan Rothschild, director of the Center for Civics, Education, and Opportunity at the Ronald Reagan Institute.